President Donald Trump announced that Medicaid plans in all 50 states will have access to "most favored nation" pricing on some prescription drugs, part of his administration's effort to lower U.S. drug prices to levels paid by other countries.
Trump said Medicaid programs in 50 states, Washington, D.C., and Puerto Rico will have access to "most favored nation" drug prices on par with what other countries pay for prescription drugs. The White House said the lower drug prices would lead to nearly $65 billion in Medicaid drug savings over the next decade.
"We're launching this program with the participation of all 50 states, red and blue," Trump said in an Oval Office announcement, accompanied by governors, on Sept. 18.
Trump has made a series of
announcements on pricing deals with drug manufacturers over the past year that he said would reduce pharmaceutical prices as well as prescription drugs listed on his direct-to-consumer website, TrumpRx.gov.
Trump announced the first drug-pricing pact with Pfizer on Sept. 30, 2025, and followed up with deals with another 16 drug manufacturers. In 2025, the Trump administration sent letters to those 17 pharmaceutical companies seeking price concessions on brand-name drugs in lieu of tariffs.
On Aug. 31, Trump announced deals with an additional nine pharmaceutical manufacturers, bringing to 26 the total number of pricing deals the administration has negotiated. Last month, Alcon, Astellas Pharma, BeOne Medicines, BridgeBio, CSL, Kyowa Kirin, Sun Pharma, Teva Pharmaceuticals and UCB signed voluntary pacts to lower drug prices. With the deals in place, the Trump administration said it has negotiated deals to lower prices for nearly 90% of brand-name drugs.
While Trump has touted these deals as cost-saving moves for consumers during Oval Office announcements, the administration hasn't publicly released terms of the voluntary agreements.
The administration's drug-pricing website, TrumpRx.gov, lists prices on dozens of brand-name fertility, insulin, weight loss and other medications. The website directs cash-paying consumers to drug manufacturers' websites or coupons that can be used at pharmacies. The site does not process insurance claims, and most people use their health insurance plan's drug benefits when filling prescriptions.
This article originally appeared on USA TODAY: Trump: Medicaid drug pricing deals reached for all 50 states
